Cell therapy is likely to succeed clinically if cells survive at the transplantation site and are protected against immune rejection. We hypothesized that this could be achieved with intrasplenic transplantation of encapsulated cells because the cells would have instant access to oxygen and nutrients while being separated from the host immune system. In order to provide proof of the concept, primary rat hepatocytes and human hepatoblastoma-derived HepG2 cells were used as model cells. Rat hepatocytes were encapsulated in 100-kDa hollow fibers and cultured for up to 28 days. Rat spleens were implanted with hollow fibers that were either empty or contained 1 × 10 7 rat hepatocytes. Human HepG2 cells were encapsulated using alginate/ poly-L-lysine (ALP) and also transplanted into the spleen; control rats were transplanted with free HepG2 cells. Blood human albumin levels were measured using Western blotting and spleen sections were immunostained for albumin. Hepatocytes in monolayer cultures remained viable for only 6-10 days, whereas the cells cultured in hollow fibers remained viable and produced albumin throughout the study period. Allogeneic hepatocytes transplanted in hollow fibers remained viable for 4 weeks (end of study). Free HepG2 transplants lost viability and function after 7 days, whereas encapsulated HepG2 cells remained viable and secreted human albumin at all time points studied. ALP capsules, with or without xenogeneic HepG2 cells, produced no local fibrotic response. These data indicate that intrasplenic transplantation of encapsulated cells results in excellent survival and function of the transplanted cells and that the proposed technique has the potential to allow transplantation of allo-and xenogeneic cells (e.g., pancreatic islets) without immunosuppression.
INTRODUCTION
into every body site including the liver, spleen, thymus, testes, brain, pancreas, lungs, kidneys, peritoneal cavity, For many diseases, cell therapy might represent a subcutaneous tissues, fat pads, and other locations (14) . simple, low-risk, and probably cost-effective alternative Cell survival is highest after intraportal or intrasplenic to whole-organ replacement. Moreover, it could allow injection (6). efficient use of donor organs, which are in critically As regards rejection, encapsulation has been shown short supply. In some instances, whole-organ replaceto allow transplantation of cells without immunosupment is not even an option. For example, transplantation pression (3,4, 11, 18) . In this technique, cells are surof pancreatic islets for type I diabetes is viewed, at least rounded by a semipermeable membrane that allows free for the time being, as the most promising alternative to exchange of oxygen, nutrients, and metabolites while insulin therapy.
excluding the passage of cells and high molecular weight Cell therapy is likely to succeed clinically only if substances such as immunocytes, antibodies, and comcells survive at the transplantation site and are protected plement factors. The problem with encapsulated cells is against immune rejection. Many cell transplantation that their survival depends on neovascularization at the techniques have been introduced over the years to implantation site and this takes time. Attempts were achieve these objectives, only to be discarded after more made to induce blood vessel formation through use of a careful evaluation and data analysis. In searching for opthree-dimensional biodegradable matrix, vascular endotimal localization, cells have been introduced virtually thelial growth factor, or capillary formation around 554 AOKI ET AL.
hollow fibers made of polymers inducing local inflam-Animals matory response (7, 9, 19, 22) . Thus far, however, no ef-Adult male SD and inbred Lewis rats (200-300 g) fective cell transplantation technique has evolved using were obtained from Harlan Sprague-Dawley, Inc. (San these methods. Additionally, placement of foreign body Diego, CA). Animals were housed in a climate-conmaterial like hollow fibers in the abdominal cavity (22) trolled (21°C) room with a 12-h light-dark cycle and may cause complications, including development of were given tap water and standard laboratory rat chow peritoneal adhesions, abscess formation, ileus, intestinal (Rodent Chow 5001, Ralston Purina, St. Louis, MO) ad perforation, etc. Use of porous membranes may also relibitum. All operations were performed under general sult in progressive fouling with proteins and cell debris.
(metaphane) anesthesia using sterile surgical technique. This could be another critical factor responsible for lack of function and death of encapsulated cells. In our previ-Rat Hepatocytes ous studies on intraperitoneal hepatocyte transplantation, Rat liver cells were harvested by in situ two-step we have encountered many of these issues. Most nota-EDTA/collagenase digestion, as described previously bly, early cell loss after transplantation of microcarrier-(6). After enrichment through a Percoll density gradient attached cells was evident and encapsulated allogeneic (10), cell viability was greater than 95%, as judged by hepatocytes induced a significant pericapsular inflamtrypan blue exclusion test. matory reaction with very few cells surviving beyond HepG2 cells were used in most experiments, because the first 2 days posttransplant (15) . this human hepatoma-derived cell line is well character-In this study we propose to use the spleen as a bed ized, secretes albumin, and it is easy to maintain in culfor encapsulated cell therapy. We hypothesized that this ture. HepG2 cells (ATCC, Manassas, VA) were cultured technique would result in excellent cell survival and in minimum essential Eagle's medium (ATCC) supplefunction because cells placed in the blood stream have mented with 10% FBS and antibiotics (penicillin G instant access to oxygen and nutrients.
10,000 U/ml, streptomycin 10,000 µg/ml, amphotericin In order to provide proof of the concept, primary rat B 25 µg/ml; Omega Scientific, Inc.). The culture mehepatocytes and human hepatoblastoma-derived HepG2 dium was changed every other day. At confluence, cells cells were used as model allogeneic and xenogeneic were detached using 0.25% trypsin/EDTA and tested for cells, respectively. The cells were entrapped in various viability; more than 95% of cells excluded trypan blue. semipermeable membranes and investigated in vitro and in vivo after transplantation in the spleen.
Encapsulation of Cells in Hollow Fibers
PVDF hollow fibers with a 100-kDa molecular MATERIALS AND METHODS weight cut-off were a gift from Spectrum Laboratories, All experiments were performed following protocols Inc. (Rancho Dominguez, CA). Hollow fibers were approved by the Institutional Animal Care and Use soaked in deionized water for 30 min at room tempera-Committee and in accordance with National Research ture and prewet for 30 min in 100% ethyl alcohol. After Council guidelines for humane care of experimental anirinsing in saline to remove alcohol, 5 × 10 5 rat hepatomals.
cytes were suspended in DMEM/5% FBS and loaded into a 4-cm-long hollow fiber using a 22-gauge Veno-Chemicals cath (Becton Dickinson Vascular Access, Sandy, UT). The two fiber ends were sealed with 6-0 silk ligatures Collagenase (type IV), purified rat albumin, FBS, (Ethicon, Somerville, NJ) and the fiber was either main-DMEM, EDTA, trypsin-EDTA, sodium alginate, CHES, tained in culture in a hormonally defined DMEM (see HEPES, PBS, and other chemicals used for liver perfuabove) or immediately implanted in the rat spleen (see sion, cell culture, cell encapsulation, measurement of albelow). bumin, ammonia and urea, and Western blotting were purchased from Sigma Chemical Co. (St. Louis, MO).
Encapsulation of Cells in ALP Capsules Rat tail collagen type I was from Collaborative Biomedical Product, (Bedford, MA) and antibiotics from Omega Encapsulation of cells was carried out using the syringe extrusion technique, as described by Cai et al. (1). Scientific, Inc. (Tarzana, CA). Vectastain ABC kits (rabbit IgG) were purchased from Vector Laboratories, Inc.
Briefly, either 1 × 10 8 HepG2 cells or 1 × 10 8 primary rat hepatocytes were suspended in 10 ml of 0.9% sodium (Burlingame, CA). Percoll was from Pharmacia Biotechnology Co. (Piscataway, NJ). EGF was purchased from chloride, which contained 1.5% sodium alginate and 0.045% (w/v) rat tail collagen type I, and antibiotics 1: in 0.1% CHES, 1.1% CaCl 2 , and then twice in 0.9% mula: viability (%) = 1 − (dead cells − background)/(all dead cells − background) × 100. Viability of hepatocytes NaCl, the microspheres were coated with 0.05% (w/v) poly-L-lysine (Sigma) for 10 min and washed with 0.1% maintained in monolayer was measured using the Cyto-Fluor system, as well. CHES, 1.1% CaCl 2 , and 0.9% NaCl. Exposure for 4 min to 0.15% sodium alginate formed the outer layer of the Measurement of Albumin Secretion. Culture medium membrane. The droplets were then washed twice in norwas collected at 2, 4, 6, 14, and 28 days after plating mal saline. The microcapsules were 800-1000 µm in and analyzed for albumin concentration by ELISA. Goat diameter and were immediately transplanted. and rabbit anti-rat albumin antibodies and peroxidaseconjugated anti-rabbit IgG were purchased from Santa In Vitro Studies Cruz Biotechnology, Inc. (Santa Cruz, CA). SuperBlock blocking buffer was from Pierce (Rockford, IL) and This set of experiments was performed to demon-ABTS solution was from Roche Molecular Biochemistrate that the fiber wall does not undergo fouling during cals (Indianapolis, IN). Plates were read at 450 nm on the culture period similar in length to subsequent in vivo an automated Microplate Reader 3550-UV (Bio-Rad, experiments. Additionally, we wanted to see whether en-Hercules, CA). Data are expressed in pg/cell and are trapment of the cells within a limited 3D space would based on total cell number at the time of inoculation/ facilitate cell aggregation and support hepatocyte differplating. entiation. Hollow fibers containing SD rat hepatocytes were placed in DMEM enriched with 10% FBS, 0.2% Measurement of Urea Nitrogen Synthesis. Ammobovine serum albumin, 20 mM HEPES, 25 mM NaHCO 3 , nium chloride (2.0 mM) was added to culture medium 1 mg/ml galactose, 30 µg/ml L-proline, 0.5 mM glutaat 2, 4, 6, 14, and 28 days after plating. After 6 h, urea mine, 10 −7 M dexamethasone, 10 mM nicotinamide, 0.5 nitrogen concentration was measured by urea nitrogen µg/ml ITS 51500, 20 ng/ml EGF, 0.1 mM L-ascorbic diagnostic kit (Roche Molecular Biochemicals, Indiaacid 2-phosphate (Asc-2P), and 100 IU/ml penicillin G napolis, IN). and 100 mg/ml streptomycin. Cell cultures were main-Microscopic Examination. Hollow fibers were retained at 37°C in humidified air/5% CO 2 with a medium moved from the dishes after 2, 4, 6, 14, and 28 days change every other day. In control cultures, primary rat and fixed in 10% buffered formalin. Light microscopic hepatocytes (5 × 10 5 cells/dish) were plated onto 60-mm examinations were performed on paraffin-embedded 5cell culture dishes (Corning, NY) coated with rat tail µm-thick sections stained with hematoxylin and eosin. collagen type I and maintained under similar culture conditions. Each cell culture experiment was repeated three times using cells harvested from different animals.
Transplantation Studies Rat hepatocytes encapsulated in hollow fibers and Hepatocyte Transplantation. A small left subcostal control monolayers of rat hepatocytes were cultured for incision was made and the spleen was exposed. Using a up to 28 days. Each experiment was repeated three times 14-gauge Venocath as the "deployment device," a 4-cmusing cells from three different rat liver cell donors.
long PVDF fiber (empty or loaded with 5 × 10 5 hepato-Measurement of Cell Viability. The viability of encytes) was inserted into the spleen through the lower capsulated cells was assessed after 2, 4, 6, 14, and 28 pole along the spleen axis. After implantation, the entry days in culture using the multiwell plate reader (Cytosite was closed with a single 4-0 silk ligature to prevent Fluor series 4000, Perceptive Biosystems, Foster City, bleeding. The following experiments were performed. CA). Briefly, using a 22-gauge Venocath the cells were Group I (n = 15): SD rats received intrasplenic transextruded from each hollow fiber onto 60-mm cell culplantation of 5 × 10 5 allogeneic SD rat hepatocytes ture dish containing DMEM. After centrifugation at seeded in a PVDF fiber. 1500 rpm, cells were suspended in PBS and 100-µl cell Group II (n = 15): SD rats received intrasplenic transaliquots were placed in the 96-well plate (Corning plantation of free 5 × 10 5 allogeneic SD rat hepato-Coaster Corporation, Cambridge, MA). Next, 100 µl of cytes. 4.0 µM ETD-1 solution (Live/Dead Viability/Cytotoxic-Group III (n = 15) SD rats received intrasplenic implanity Kit; Molecular Probe, Eugene, ON) was added to tation of an empty PVDF fiber. This was done to each well and, after 30 min, red fluorescence was meadetermine the biocompatibility of PVDF fibers. sured using the Cyto-Fluor (fluorescence emission: 645/ 20; fluorescence excitation: 530/25). After adding 50 µl Rats from each group were killed in batches of three to five after 2, 4, 6, 14, and 28 days. At sacrifice, the of Triton-X to each well (to kill all of the remaining viable cells), red fluorescence was measured again and spleens were removed and fixed in 10% buffered formalin. Light microscopic examination was performed on hepatocyte viability was calculated according to the for-paraffin-embedded 5-µm-thick sections stained with he-6 h in Leibovitz's L-15 Medium (GIBCO) and then fixed with 0.1% glutaraldehyde for 5 min. The cells matoxylin and eosin.
were placed at 4°C in SuperBlock blocking buffer in HepG2 Cell Transplantation. Inbred Lewis rats were PBS (Pierce) overnight. After washing three times with used as transplant recipients. Approximately 1 × 10 7 PBS, rat sera diluted 1:40 in PBS were added for 2 h at microencapsulated HepG2 cells suspended in 1 ml of room temperature. All samples were analyzed in tripliphysiologic saline were injected into the spleen using a cate. After washing three times with PBS, 1:1000 goat 14-gauge Venocath (Becton Dickinson Vascular Access, anti-rat IgG labeled with horseradish peroxidase was Sandy, UT). Hemostasis at the injection site was added for 1 h at room temperature. ABTS (Roche Moachieved with a 4-0 silk ligature. There were four experlecular Biochemicals) was used to reveal peroxidase acimental groups.
tivity. In negative controls, rat serum was omitted. Plates Group A rats (n = 35) received intrasplenic transplantawere read on an automated Microplate Reader 3550-UV tion of encapsulated HepG2 cells.
(Bio-Rad). Group B rats (n = 35) received intrasplenic transplanta-Microscopic Examination. The specimens were fixed tion of free HepG2 cells.
in 10% formalin, dehydrated, and embedded in paraffin. Group C rats (n = 35) received intrasplenic transplanta-Sections 7 µm thick were stained with hematoxylintion of empty microcapsules.
eosin. Additionally, human albumin was detected in Group D rats (n = 35) received intrasplenic transplanta-HepG2 cell implants using standard immunohistochemition of 1 × 10 7 microencapsulated syngeneic rat hepacal technique. Rabbit anti-human albumin antibody tocytes. This particular group was used to determine (DAKO Co.) was used as the primary antibody and antithe survival of intrasplenically seeded cells when no rabbit biotin-conjugated IgG (Vector Laboratories Inc.) immune reaction was expected to develop around the was used as the secondary antibody. The slides were capsule wall.
developed with diaminobenzine Rats from each group were killed in batches of five RESULTS rats each at 1, 3, 5, 7, 14, and 28 days posttransplantation. At sacrifice, blood was collected by aortic puncture
In Vitro Studies and the spleen was removed and processed for morpho-Hepatocytes that were cultured as monolayers relogic examination.
mained viable for 6-10 days only, although between day Detection of Human Albumin in Rat Serum. This was 2 and day 6 postplating there was a modest, but significarried out using the Western blot analysis. Briefly, socant, drop in viability (97.0 ± 0.4% at 2 days; 87.1 ± dium dodecylsulfate-polyacrylamide gel electrophoresis 1.9% at 4 days; 86.2 ± 1.1% at 6 days; all differences was performed in a vertical tank (Mini-Protein II Elecat p < 0.01). After about 10 days, the cultures were trophoresis cell; Bio-Rad). Rat serum (diluted 1:10,000 stopped because of progressive cell detachment and in PBS) was diluted 1:2 in Laemmli sample buffer (Biodeath. In contrast, the cells cultured in PVDF hollow Rad) and denatured by heating for 3 min at 100°C. Eight fibers maintained high viability throughout the study microliters of this solution was deposited on a 5% stackperiod at a similar level (89.4 ± 7.0% at 2 days; ing gel and a 12% separating gel. Migration was run at 87.1 ± 4.2% at 4 days; 81.2 ± 6.6% at 6 days; 80.4 ± 20 mA for 15 min and then at 40 mA for 1 h. Reference 5.8% at 14 days; 79.2 ± 5.0% at 28 days; all differences proteins (Bio-Rad) were run simultaneously in a control at p > 0.05). Moreover, after 28 days encapsulated hepalane. Separated proteins were transferred onto nitrocellutocytes showed normal morphology and formed cordlose membrane in Semi-Dry Transfer Cell (Bio-Rad), like structures resembling the liver microarchitecture which was then saturated with 5% nonfat milk in PBS (Fig. 1) . for 2 h at room temperature and 1:500 rabbit anti-human During the first 6 days in culture, control cultures albumin antibody (DAKO Co., Carpinteria, CA) was approduced 3-4 times more albumin (pg/cell) than hepatoplied at 4°C overnight. After three washings with PBScytes maintained in hollow fibers. Encapsulated cells T, a peroxidase-conjugated goat anti-rabbit antibody produced albumin at a similar level at day 2, 4, 6, and (Santa Cruz Biotechnology Inc.) was applied for 30 min 14 in culture; only at termination of the culture period at room temperature. Western blotting detection reagents (i.e., after 4 weeks) was there a slight but significant (ECL; Amersham Pharmacia Biotech, Inc., Piscataway, drop (p < 0.05) in albumin secretion when compared NJ) revealed the reaction.
with that found at all other time points studied ( Fig. 2A) . When both culture systems were challenged with 2.0 Detection of Anti-HepG2 Antibodies in Rat Serum. This was carried out using ELISA, as described by Wen mM/L of ammonium chloride, the synthesis of urea followed the pattern seen with albumin secretion; urea pro-et al. (21) . Briefly, HepG2 cells were cultured in 96well microtiter plates (Corning Coaster Corporation) for duction at day 28 in culture was significantly lower (p < 0.01) than that found at all earlier time points stud-at all time points studied and no pericapsular fibrosis ied (Fig. 2B ).
was noted (Fig. 4A ). The cells stained positive for human albumin (Fig. 4B) , which was also detected in all Transplantation Studies blood samples by Western blotting (Fig. 5 ).
Intrasplenic Transplantation of Hepatocytes in PVDF
In group B rats transplanted with free HepG2 cells, Fibers. Empty fibers produced only a mild fibrotic reacviable cells could be found in the spleens for 7 days tion. The presence of allogeneic cells in the fibers did only. Additionally, human albumin was detected only not aggravate perifiber response (Fig. 3A-D) . Morein blood samples obtained at 1, 3, 5, and 7 days after over, group I cells transplanted in 100-kDa fibers retransplantation ( Fig. 5) . mained viable throughout the study period, while group After transplantation of free HepG2 cells, serum lev-II free hepatocyte transplants survived in the spleen for els of anti-HepG2 antibodies increased sharply at 3 days 6 days only.
after transplantation but from day 7 onward returned to the level seen in rats transplanted with empty capsules Intrasplenic Transplantation of Cells in ALP Cap- (Fig. 6 ). In group A rats transplanted with microencapsules. In group A rats transplanted with microencapsulated HepG2 cells, ALP capsules contained viable cells sulated HepG2 cells, serum levels of anti-HepG2 anti- bodies showed no significant changes when compared ferentiation and the need for rapid neovascularization to provide the grafted cells with oxygen and nutrients. The with group C control animals transplanted with empty ALP capsules (Fig. 6 ).
latter might be especially difficult to achieve when transplanted cells are enclosed in a semipermeable mem-Group D rats transplanted with microencapsulated syngeneic rat hepatocytes showed excellent cell survival brane.
Because of these considerations we decided to exam-and no pericapsular fibrosis.
ine whether the spleen could be used for encapsulated DISCUSSION cell therapy. We hypothesized that this technique would result in excellent cell survival and function because the For a cell transplantation method to be useful, the technique must be simple, result in early cell survival, cells would have instant access to oxygen and nutrients, which are being transported in blood perfusing the and allow transplantation of an adequate number of cells that express differentiated functions in vivo. Although splenic pulp.
In order to test this hypothesis, primary rat hepato-significant progress has been achieved in cell therapy, the optimal site for cell implantation and transplantation cytes and human hepatoma cells (HepG2) were used as an experimental model of allogeneic transplantation and technique has not yet been determined. Many investigators tried intraperitoneal infusion of cells (2, 3, 14, 17, 21) . discordant xenografting. We chose rat hepatocytes rather than pancreatic islet cells because hepatocyte isolation However, this mode of cell delivery is limited because of the necessity for introduction of various types of ma-is much simpler and less expensive. However, the rat spleen is too small to accommodate sufficient number trix to provide a substratum for cell attachment and dif- of encapsulated hepatocytes so that therapeutic effects we show for the first time that implantation of encapsulated cells in the spleen results in excellent survival and could be measured in animal models of liver failure (e.g., inborn errors of liver metabolism, toxic and surgi-function of the transplanted allogeneic and xenogeneic cells. We attribute these effects to the fact that the hol-cally induced liver injury). In order to overcome this obstacle and be able to detect the function of a small low fibers and ALP capsules containing cells were in direct contact with the blood traversing the splenic pulp. number of transplanted cells, we used HepG2 cells because their function can be monitored by testing rat se-Therefore, the cells did not suffer from immediate/early anoxia and they received adequate nourishment. Re-rum for the presence of human albumin.
That the spleen is a comfortable bed for cell therapy markably, even though the spleen as a transplantation site is not immunologically privileged, survival and and that encapsulated cell technologies, including the one employed in this study, allow transplantation with-function of encapsulated xenogeneic cells were excellent. Moreover, there was no fibrosis around the ALP out immunosuppression is well documented in the literature (1-4,6, 11, 12, 14, [16] [17] [18] 21, 22) . What has never been capsules containing xenogeneic HepG2 cells, and a thin layer of fibroblasts surrounding the PVDF hollow fibers tried, is the combination of these two strategies with the aim to improve the results of cell therapy. In this regard, containing allogeneic hepatocytes resulted from foreign Figure 5 . Detection of human albumin in rat sera. Group A rats were transplanted with encapsulated HepG2 cells, whereas group B rats received transplantation of free HepG2 cells. Human albumin was detected in group A rats at all time points studied (lanes 1-6). In group B rats, human albumin was detected in serum samples obtained on days 1, 3, and 7 (lanes 7-10), but not on days 14 and 28 (lanes 11-12) after transplantation. Human albumin was not detected in serum samples from group C (empty capsules, lane E) and group D (transplantation of syngeneic rat hepatocytes, lane S) rats.
out percutaneously or through a minimally invasive laparoscopic approach, as described previously (13) . • The spleen is a well-defined organ and the fate of transplanted cells (e.g., tagged cells) could be studied using an array of modern diagnostic techniques. • If one considers the proposed technique for transplantation of pancreatic islets, it is worth noting that insulin would be delivered directly to the liver (i.e., in a physiological manner).
In conclusion, intrasplenic transplantation of encapsulated cells results in excellent survival and function of the transplanted cells. This novel approach to encapsulated cell therapy has the potential to allow transplantation of allogeneic and xenogeneic cells without Figure 6 . Measurement of anti-HepG2 antibodies in rat serum immunosuppression (e.g., pancreatic islets, genetically samples. In group B rats, serum levels of anti-HepG2 antibodengineered cells secreting specific therapeutic comies increased sharply 3 days after transplantation but from day pounds). 7 onward returned to the level seen in rats transplanted with empty capsules. Group A rats showed no increase in serum levels of anti-HepG2 antibodies when compared with group C
